Showing results (1-10 of 207) with videos related to
Sort By:
Pageof 21
Neurodegenerative Disease Management|January 10, 2022
Evidence base for investigative and therapeutic modalities in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathyHendrik Stephan Goedee, Yusuf A RajaballyMuscle & Nerve|April 21, 2020
Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemicYusuf A Rajabally, H Stephan Goedee, Shahram Attarian, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 9, 2021
Iatrogenic immune-mediated neuropathies: diagnostic, epidemiological and mechanistic uncertainties for causality and implications for clinical practiceH Stephan Goedee, Shahram Attarian, Thierry Kuntzer, et al.Journal of Neurology, Neurosurgery, and Psychiatry|October 15, 2013
Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospectsYusuf A RajaballyInflammation & Allergy Drug Targets|March 29, 2012
Treatment of Guillain-Barré syndrome: a reviewYusuf A RajaballyImmunotargets and Therapy|March 4, 2024
Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future OutlooksYusuf A RajaballyNeurodegenerative Disease Management|October 19, 2017
Unconventional treatments for chronic inflammatory demyelinating polyneuropathyYusuf A RajaballyMuscle & Nerve|January 6, 2015
Long-term immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathyYusuf A RajaballyExpert Review of Neurotherapeutics|January 31, 2022
Contemporary challenges in the diagnosis and management of chronic inflammatory demyelinating polyneuropathyYusuf A RajaballyNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 1, 2022
Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré SyndromeYusuf A RajaballyPageof 21